Lumantas, Kim Daniell F.

HRN: 21-53-02  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/09/2022
CEFTRIAXONE 1G (VIAL)
07/09/2022
07/15/2022
IV DRIP
2 Grams
Q24
Seizure Disroder
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Central Nervous System    Compliance to guidelines: Guideline Not Available

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: